|
47
|
143
|
4dgeC |
Trimcyp cyclophilin domain from macaca mulatta: h70c mutant, hiv-1 ca(o-loop) complex |
|
16
|
99
|
4cprA |
Macrocyclic transition-state mimicking hiv-1 protease inhibitors encompassing a tertiary alcohol |
|
16
|
99
|
4cpuA |
Macrocyclic transition-state mimicking hiv-1 protease inhibitors encompassing a tertiary alcohol |
|
15
|
99
|
4cpwA |
Macrocyclic transition-state mimicking hiv-1 protease inhibitors encompassing a tertiary alcohol |
|
28
|
75
|
4cocA |
Hiv-1 capsid c-terminal domain mutant (y169l) |
|
15
|
99
|
4cptA |
Macrocyclic transition-state mimicking hiv-1 protease inhibitors encompassing a tertiary alcohol |
|
16
|
99
|
4coeA |
Macrocyclic transition-state mimicking hiv-1 protease inhibitors encompassing a tertiary alcohol |
|
0
|
20
|
4b18B |
The crystal structure of human importin alpha 5 with tert nls peptide |
|
56
|
155
|
4ahuA |
Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification |
|
16
|
99
|
3zptA |
Design and synthesis of p1-p3 macrocyclic tertiary alcohol comprising hiv-1 protease inhibitors |
|
60
|
154
|
4ahsA |
Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification |
|
16
|
99
|
3zpsA |
Design and synthesis of p1-p3 macrocyclic tertiary alcohol comprising hiv-1 protease inhibitors |
|
58
|
153
|
4ahvA |
Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification |
|
16
|
99
|
4a6bA |
Stereoselective synthesis, x-ray analysis, and biological evaluation of a new class of lactam based hiv-1 protease inhibitors |
|
16
|
99
|
3zpuA |
Design and synthesis of p1-p3 macrocyclic tertiary alcohol comprising hiv-1 protease inhibitors |
|
15
|
99
|
4a6cA |
Stereoselective synthesis, x-ray analysis, and biological evaluation of a new class of lactam based hiv-1 protease inhibitors |
|
55
|
154
|
4ahtA |
Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification |
|
59
|
155
|
4ahrA |
Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification |
|
59
|
156
|
4ah9A |
Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification |
|
46
|
153
|
3wnfA |
Cyclic hexapeptide ckidnc in complex with hiv-1 integrase |
|
48
|
153
|
3wnhA |
Cyclic hexapeptide pkzdnv in complex with hiv-1 integrase |
|
47
|
154
|
3wneA |
Cyclic hexapeptide pkidng in complex with hiv-1 integrase |
|
49
|
153
|
3wngA |
Cyclic hexapeptide pkidnp in complex with hiv-1 integrase |
|
18
|
99
|
3vf7A |
Crystal structure of hiv-1 protease mutant l76v with novel p1'-ligands grl-02031 |
|
18
|
99
|
3vf5A |
Crystal structure of hiv-1 protease mutant i47v with novel p1'-ligands grl-02031 |
|
53
|
165
|
3v1oA |
Crystal structures of the reverse transcriptase-associated ribonuclease h domain of xenotropic murine leukemia-virus related virus |
|
17
|
99
|
3vfbA |
Crystal structure of hiv-1 protease mutant n88d with novel p1'-ligands grl-02031 |
|
48
|
165
|
3v1rA |
Crystal structures of the reverse transcriptase-associated ribonuclease h domain of xmrv with inhibitor beta-thujaplicinol |
|
47
|
157
|
3v1qA |
Crystal structures of the reverse transcriptase-associated ribonuclease h domain of xenotropic murine leukemia-virus related virus |
|
18
|
99
|
3vfaA |
Crystal structure of hiv-1 protease mutant v82a with novel p1'-ligands grl-02031 |
|
15
|
99
|
3upjA |
Human immunodeficiency virus type 2 protease mutant with lys 57 replaced by leu (k57l) complex with u096333 [4-hydroxy-3-[1-(phenyl)propyl]-7-methoxycoumarin] |
|
16
|
99
|
3uf3A |
Crystal structure of multidrug resistant hiv-1 protease clinical isolate pr20 |
|
49
|
588
|
5g2xC |
Structure a of group ii intron complexed with its reverse transcriptase |
|
16
|
99
|
3ucbA |
Crystal structure of multidrug resistant hiv-1 protease clinical isolate pr20 in complex with darunavir |
|
16
|
99
|
3uhlA |
Crystal structure of multidrug resistant hiv-1 protease clinical isolate pr20 in complex with p2-nc substrate analog |
|
19
|
99
|
3ufnA |
Crystal structure of multidrug resistant hiv-1 protease clinical isolate pr20 in complex with saquinavir |
|
17
|
99
|
3u7sA |
Hiv pr drug resistant patient's variant in complex with darunavir |
|
18
|
99
|
3ttpA |
Structure of multiresistant hiv-1 protease in complex with darunavir |
|
100
|
367
|
5froA |
Crystal structure of the prototype foamy virus (pfv) intasome in complex with magnesium and the insti xz446 (compound 4f) |
|
18
|
99
|
3togA |
Hiv-1 protease - epoxydic inhibitor complex (ph 9 - monoclinic crystal form p21) |
|
19
|
103
|
3tkgA |
Crystal structure of hiv model protease precursor/saquinavir complex |
|
17
|
99
|
3tofA |
Hiv-1 protease - epoxydic inhibitor complex (ph 6 - orthorombic crystal form p212121) |
|
16
|
99
|
3tkwA |
Crystal structure of hiv protease model precursor/darunavir complex |
|
17
|
99
|
3tlhA |
Structural studies of hiv and fiv proteases complexed withan efficient inhibitor of fiv pr |
|
18
|
99
|
3tl9A |
Crystal structure of hiv protease model precursor/saquinavir complex |
|
18
|
99
|
3tohA |
Hiv-1 protease - epoxydic inhibitor complex (ph 9 - orthorombic crystal form p212121) |
|
106
|
424
|
3tamB |
Crystal structure of hiv-1 reverse transcriptase (k103n mutant) in complex with inhibitor m06 |
|
17
|
99
|
3th9A |
Crystal structure of hiv-1 protease mutant q7k v32i l63i with a cyclic sulfonamide inhibitor |
|
80
|
226
|
3tirA |
Pseudo-atomic model of the rous sarcoma virus capsid hexamer |
|
160
|
557
|
3tamA |
Crystal structure of hiv-1 reverse transcriptase (k103n mutant) in complex with inhibitor m06 |
